Joshi J Alumkal

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. pmc Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers
    Joshi J Alumkal
    Oregon Health and Science University, Knight Cancer Institute, Portland, OR 97239, USA
    Cancer Discov 2:979-81. 2012
  2. pmc Effect of DNA methylation on identification of aggressive prostate cancer
    Joshi J Alumkal
    Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon, USA
    Urology 72:1234-9. 2008
  3. pmc C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results
    Renee C Prins
    Division of Hematology and Medical Oncology, Oregon Health and Science University Sam Jackson Park Rd, Portland, OR 97239, USA
    Urol Oncol 30:33-7. 2012

Collaborators

Detail Information

Publications3

  1. pmc Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers
    Joshi J Alumkal
    Oregon Health and Science University, Knight Cancer Institute, Portland, OR 97239, USA
    Cancer Discov 2:979-81. 2012
    ..This finding clarifies molecular features of these TMPRSS2-ERG fusion-negative tumors and may have implications for how to treat this prostate cancer subtype...
  2. pmc Effect of DNA methylation on identification of aggressive prostate cancer
    Joshi J Alumkal
    Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon, USA
    Urology 72:1234-9. 2008
    ..DNA methylation of promoter regions leads to gene silencing in many cancers. In this study, we assessed the effect of DNA methylation on the identification of recurrent prostate cancer...
  3. pmc C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results
    Renee C Prins
    Division of Hematology and Medical Oncology, Oregon Health and Science University Sam Jackson Park Rd, Portland, OR 97239, USA
    Urol Oncol 30:33-7. 2012
    ..CRP is a readily measurable biomarker that has the potential to improve prognostic models and should be validated in a prospective clinical trial...